|Articles|May 1, 2004
Topical DNA fragment protects mice from UV-induced skin cancer
Boston - Topical application of the small DNA fragment thymidine dinucleotide (pTT) can activate innate defense mechanisms in skin, which ultimately protect against development of skin cancers, according to a study by reasearchers at the Boston University School of Medicine.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5













